LAN TRAN: Open Payments
NPI 1235620675 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 46 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $459 · 2025 $1,064
Food & beverage: $974Education: $90
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $133 |
| Celgene Corporation | 4 | $78 |
| PFIZER INC. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| ABBVIE INC. | 3 | $74 |
| Daiichi Sankyo Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Eisai Inc. | 2 | $54 |
| Janssen Biotech, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: OPDIVO, REBLOZYL, SCEMBLIX, IBRANCE, Lenvima, Enhertu, DARZALEX, MONJUVI.
Industry payments across GA — which companies pay providers there.
